International Journal of Clinical Medicine
Vol.07 No.09(2016), Article ID:70996,13 pages

Risk Factors for Stroke in Sulaimaniyah Iraqi Kurdistan Region-Iraq

Ahmed Saeed Mohamed1, Mohamed A. M. Alshekhani2

1Sulaimaniyah General Teaching Hospital, Sulaimaniyah, Iraqi Kurdistan, Iraq

2Department of Medicine, Directory of Health, Sulaimaniyah, Iraqi Kurdistan Region, Iraq

Copyright © 2016 by authors and Scientific Research Publishing Inc.

This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).

Received: August 15, 2016; Accepted: September 26, 2016; Published: September 29, 2016


Background: Stroke is a frequent medical problem and a leading cause of death and disability worldwide. Several conditions and lifestyle factors have been associated with stroke. Aim: To evaluate risk factors in stroke patients in Sulaimani city. Results: 110 patients with stroke were included in this study, hypertension was found to be the most common risk factor in current study. Out of 110 cases, 83 (75.5%) were hypertensive. Peak stroke-prone age was (60 - 69) year for male, (70 - 79) year for female. We found a statistically significant relation between level of TSC, LDL with ischemic stroke (r = 0.4047, P < 0.0001) and (r = 0.4052 P < 0.0001) respectively. While there was a significant inverse relation between HDL and ischemic stroke (Correlation coefficient = −0.4862, P < 0.0001). On the other hand, there was no significant relation between level of TG and ischemic stroke (r = 0.2403, P < 0.0114). Also correlation statistic between TSC/HDL, LDL/HDL and result of CT scan, showed that there is statistical significance correlation between infarction and value of atherogenic index, (r = 0.5301, P < 0.0001, r = 0.4990, P < 0.0001) respectively, but there is no correlation between haemorhage & the index. Conclusion: Hypertension is the leading risk factor of stroke. It is therefore essential to detect and treat hypertension at its outset. High value of atherogenic index mostly associated with ischemic stroke .while no relation found with haemorhagic stroke.


Stroke, Risk Factors, CT Scan, Brain, Lipid Profile, Echocardiography

1. Introduction

Cerebrovascular diseases include disorders in which there is a disturbance of blood supply to the brain. Stroke occurs when an artery supplying blood to a part of the brain suddenly becomes blocked (ischaemic stroke) or bleeds (haemorrhagic stroke), accounting for about 85% & 15% of cases respectively [1] . This causes loss of function of part of the brain and may affect functions [1] [2] . Transient ischaemic attack (TIA), sometimes called “mini-stroke”, is a temporary manifestation of cerebrovascular disease [3] . Stroke is a major public health problem, being among the top three causes of death in most countries. It affects the brains of almost a half million people every year. Ischemic stroke accounts for more than 80 percent of all strokes. Intracranial Haemorrhage (ICH) usually accounts for 10 to 30 percent of cases depending on the origin of the patient, with greater relative frequencies reported in Asians and blacks [4] .

Stroke is classified into two major types: Brain ischemia due to thrombosis, embolism, or systemic hypoperfusion. Brain hemorrhage due to intracerebral hemorrhage or subarachnoid hemorrhage [5] . Risk factors for stroke comprise both modifiable and nonmodifiable characteristics; no modifiable include Age: Doubles for each decade of life after age 55(6). Heredity (family history) and race: Greater if a parent, grandparent, sister or brother has had stroke [6] [7] . Gender: Stroke is more common in men than in women. In most age groups, more men than women will have a stroke in a given year [8] . Prior stroke, TIA or heart attack―The risk of stroke for someone who has already had one is many times that of a person who has not. TIAs are strong predictors of stroke. A person who’s had one or more TIAs is almost 10 times more likely to have a stroke than someone of the same age and sex who hasn’t [9] . While modifiable risk factors include: High blood pressure―High blood pressure is the most important controllable risk factor for stroke [10] [11] . Cigarette smoking―In recent years, studies have shown cigarette smoking to be an important risk factor for stroke [11] . Diabetes mellitus―Diabetes is an independent risk factor for stroke. Many people with diabetes also have high blood pressure, high blood cholesterol and are overweight [11] . Carotid or other artery disease―The carotid arteries supply blood to brain. A carotid artery narrowed by fatty deposits from atherosclerosis may become blocked by a blood clot. Atrial fibrillation―This heart rhythm disorder raises the risk for stroke. Other heart disease―People with coronary heart disease or heart failure have a higher risk of stroke than those with hearts that work normaly. Dilated cardiomyopathy, heart valve disease and some types of congenital heart defects also raise the risk of stroke [11] . High blood cholesterol―People with high blood cholesterol have an increased risk for stroke. Also, it appears that low HDL (“good”) cholesterol is a risk factor for stroke [10] [11] . Poor diet―Diets high in saturated fat and cholesterol can raise blood cholesterol. Diets high in sodium (salt) can contribute to increased blood pressure. Diets with excess calories can contribute to obesity [9] - [11] . Physical inactivity and obesity―Being inactive, obese or both can increase your risk of high blood pressure, high blood cholesterol, diabetes, heart disease and stroke [11] - [17] .

2. Patients and Methods

This cross sectional study was approved by the scientific committee of the directory of health in sulaimani city and was conducted to evaluate risk factors for stroke in those patients admitted to the General Teaching Hospital in Sulaimani city-Iraq, from November 2009 to November 2010. The total sample size was 110 patients.

2.1. Inclusion & Exclusion Criteria

All patient with proven stroke by CT-scan included in this study, those who have no CT-scan & having space occupying lesion on CT where excluded from study. Transthoracic echocardiography performed using PHILIPS EnVisor C machine combines real-time two-dimensional imaging of the heart and cardiac valves. All patients in the study had a C.T scan (SOMATOM AR.SP, version B41A) of the brain (without contrast) to confirm the clinical diagnosis of stroke and the results was read by expert radiologists within 24 hours of presentation [17] . Estimation of lipid profile (TSC, TG, HDL, and LDL) was done using TECO DIAGNOSTICS kits, Interpretation of result was done according to the National Cholesterol Education Program (ATP III Guidelines). Atherogenic index measured by dividing LDL over HDL, also ratio of TSC/HDL was measured [18] [19] .

2.2. Statistical Analyses

Data were translated into codes using a specially designed coding sheet, and then converted to computerized database. An expert statistical advice was sought and statistical analyses were done using (SPSS) (Statistical Package for Social Science) version 17 computer software. The degree of association between the variables (lipid profile and CT scan results) calculated using Rank correlation i.e. Spearman’s rho and/or Kendall’s tau rank correlation coefficients. P-value < 0.05 regarded as statistically significant.

3. Results

A total of 110 patients with stroke were enrolled in the study; 73 ischemic strokes and 27 hemorrhagic ones (Table 1). Altogether, males (59%) outnumbered females (41%). Peak stroke-prone age was (60 - 69) year for male, (70 - 79) year for female. Table 2 shows the patients’ age and gender distribution, males out number females in most age groups. Hypertension was found to be the most common risk factor in current study (75.5%),. Out of 110 cases, 83 (75.5%) were hypertensive, followed by cigarette smoking (52.7%) and ischemic heart disease (37.3%) (Table 3). The fasting serum total cholesterol was within its normal reference range in 84.5% of the patients. However, serum LDL levels were elevated in 25.4% and serum HDL was low in 78.2.% of the patients, We found a statistically significant relation between level of TSC, LDL with ischemic stroke (r = 0.4047, P < 0.0001) and (r = 0.4052 P < 0.0001) respectively (Table 4). While there was a significant inverse relation between HDL and ischemic stroke (Correlation coefficient = −0.4862, P < 0.0001).On the other hand, there was no significant relation between level of TG and ischemic stroke (r = 0.2403, P < 0.0114) (Table 4). Also correlation statistic between TSC/HDL, LDL/HDL and result of CT scan, showed that there is statistical significance correlation between infarction and value of atherogenic index, (r = 0.5301, P < 0.0001, r = 0.4990, P < 0.0001) respectively, but there is no correlation

Table 1. Stroke subtype, note that ischemic stroke is more frequent than hemorrhagic stroke, (73% versus 27%).

Table 2. Age and sex distribution of stroke.

Table 3. Risk factors in stroke patients in decreasing order of frequency; note that hypertension was the commonest one.

between haemorhage and the index. Trans-thoracic echocardiography showed that 56.4% of the patients have hypertensive heart disease and that 27.3% of the patients demonstrated evidence of ischemic heart disease; the study was unremarkable in 15.5% of the patients (Table 5).

4. Discussion

The patients included in the present study representa random sample of patients hospitalized in medical department with acute stroke with variable duration of in-patient care. The frequency of these risk factors in our study distributed as follows (in decreasing order):

Table 4. Fasting serum lipid profile results in strokes patients (n = 110).

Table 5. Transthoracic echocardiographic findings of stroke patients. This table shows that “hypertensive heart disease” is the main finding (56.3%).

Hypertension is the commonest risk for stroke (75%), smoking (52%), ischemic heart disease (37%), history of prior stroke (36%), family history of stroke (30%), diabetes mellitus (21%), atrial fibrillation (19%), valvular heart disease (8%), oral contraceptive pills (8%), increased hematocrit (7%), alcohol (6%), and anticoagulant use (1%).

Stroke rates increase dramatically with age. About two thirds of all strokes occur after the age of 65. in our study the most affected age group was between (60 - 70) years of age [20] .

Stroke is more common in male sex than female’s one according to many series [20] [21] ; in our study it was also more common in male sex (59%) as compared to that of female (41%).

Stroke subtype: Ischemic stroke had been reported to be more frequent than hemorrhagic stroke and accounted for 73% versus 27% of that of haemorrhagic stroke in our study. This percentage of hemorrhagic stroke (27%) is a slightly higher than the western figures (especially in USA, which is around (10% - 15%), but coincides with the results of studies done on Asian populations [22] - [24] .

Hypertension: The above findings indicate that hypertension is the commonest risk factor identified and is the most important risk factor for stroke, and this observation is consistent with other studies. For people of all ages and both sexes, higher levels of both systolic and diastolic blood pressure have been associated with an increased incidence of ischemic and hemorrhagic stroke [25] - [34] .

Smoking: Smoking has been seen as a risk factor for stroke incidence in some studies [35] [36] . In the Oslo study of men, smoking was found to be a stronger predictor of stroke mortality than incidence [37] . A dose response was seen with cigarette smoking, and smoking cessation reduced the stroke incidence risk [38] . Other studies have shown this effect, which suggests that a real way to reduce both stroke occurrence and mortality is to encourages moking cessation. In line with these observation, in our study 58 cases (among 110 cases) were smoker.

Diabetes mellitus: In our study most cases were of type 2 diabetes, and its contribution to stroke (21%) was a little bit higher than many other studies (5% - 10%)]. This difference might be explained by the fact that some cases were previously undiagnosed and many others were poorly controlled. Many studies have observed an independent association―in both men and women―of diabetes with an elevated risk of stroke [39] , with relative risks of ischemic stroke and stroke of all types of 1.8 to 3.0 for both diabetic men and diabetic women [40] [41] .

Dyslipidemia: The relation between serum cholesterol levels and the risk of stroke is not clear. A U-shaped relation between the serum level of total cholesterol and the risk of stroke of all types has been proposed, derived from an inverse association with hemorrhagic stroke and a direct association with ischemic stroke. The inverse relation with hemorrhagic stroke has been observed in numerous studies of populations of Japanese origin [41] - [44] .

In our study, we found that patients with high total serum cholesterol (Correlation coefficient r = 0.4047; P < 0.0001; 95% Confidence interval for r = 0.2353 to 0.5503) and low HDL cholesterol (Correlation coefficient r = −0.4862; P < 0.0001; 95% Confidence interval for r = −0.6173 to −0.3289) were mostly associated with ischemic stroke; we measured the atherogenic index (LDL/HDL cholesterol) and the atherogenic ratio (total serum cholesterol/HDL cholesterol) and found that a statistically significant association was established between high atherogenic index (Correlation coefficient r = 0.4990; P < 0.0001; 95% Confidence interval for r = 0.3439 to 0.6276) and high atherogenic ratio (Correlation coefficient r = 0.5301; P < 0.0001; 95% Confidence interval for r = 0.3807 to 0.6526) with ischemic stroke. Also we found that a normal total serum cholesterol does not confirm a protection against stroke, because 28 patients had a high LDL (more than 160 mg/dl; n = 110) and 86 patients had a low HDL cholesterol (less than 40 mg/dl; n = 110) within the normal total cholesterol range.

Alcohol: The relation of moderate alcohol consumption to the risk of stroke has not been conclusively determined. Several methodologic problems have hampered research, including the contamination of the reference group of lifelong abstainers with former drinkers, which may contribute to the J-shaped relation observed in many studies. Only 6% patients in our study were drinkers; this small number is consistent with other studies about alcohol and stroke [45] [46] .

Oral contraceptive pill: Higher-dose formulations of oral contraceptives were found to increase the risk of stroke in some subgroups of women, including women over 35 years of age, cigarette smokers, women with hypertension, and women with a history of migraine headaches [47] [48] . A recent meta-analysis combined the results of 47 case- control and cohort studies and established a relative risk among users, an increased risk of stroke have been observed [49] .

In our study 9 cases (8%) had history of taking oral contraceptive pills, six of them were ischemic stroke, which can be explained by its adverse effects, such as increased thrombosis and three cases were haemorrhagic stroke which might be related to its effect on raising blood pressure [50] .

Atrial fibrillation: Abnormal contraction of the atria may result in thrombus formation. The risk of stroke secondary to thromboembolism related to atrial fibrillation is approximately 3% to 5% per year [51] . In a study of primary prevention in patients with atrial fibrillation, the annualrisk of stroke was 6.3% with no treatment, 3.6% with aspirin therapy, and 2.3% with warfarin therapy [52] . In our study out of 110 stroke patients 21 cases (19%) had atrial fibrillation, 20 cases were ischemic stroke , and only 1 case was hemorrhagic stroke which had history of using anticoagulant drug (warfarin), possibly been over anticoagulated. Randomized treatment trial data have shown that anticoagulation with warfarin can reduce the relative risk of stroke by 70% to 80% in the highest-risk groups(age older than 75 years, prior thromboembolic event, history of hypertension, impaired left ventricular function and diabetes), with low risk of hemorrhagic complications and acceptable adverse-effect profiles [53] . In the current study only 2 cases (1.8%) were they had history of using anticoagulant (both of them had AF), one ischemic and the other was hemorrhagic stroke, which might be one of them under treated or the other been over treated respectively.

Ischemic heart disease: People with coronary heart disease or heart failure have a higher risk of stroke than those with hearts that work normally [54] [55] .

In the present study 41 cases (37%) had previous history of coronary heart disease and also 17 cases (27%) by transthoracic echocardiography had this disease.

12-Increased hematocrit: A high hematocrit is expected to be associated with an increased risk of thrombosis or embolism. Numerous reports from patients with polycythemia vera and pseudopolycythemia confirm a correlation of elevated hematocrit levels and the incidence of thrombosis [56] [57] . The Framingham study established a positive correlation between the hematocrit value and the risk of cerebral infarction [58] and in a prospective study a hematocrit level higher than 0.51 was found to be an independent risk factor for stroke [59] . Incyanotic congenital heart disease, exceedingly high hematocrit values of up to 0.80 have been recorded, and cerebral andpulmonary infarcts as well as cerebral venous thrombosis correlate with hematocrit levels [60] . In line with these observation, in our study 8 cases (among 110 cases) were detected to have a high hematocrit level all of them were ischemic stroke exept one.

Transthoracic echocardiography: Echocardiography is the investigation of choice when a cardiac source of embolism is suspected. However, debate persists about which patients with a stroke or thromboembolism requires imaging. This is in part a result of the increasing pressure on already overloaded echo services and a need for prioritization, but it also reflects considerable variation in physicians [61] - [64] .

Echocardiographic finding in our patients was like that: Hypertensive heart disease (56%), Ischemic heart disease (27%), Normal (15%), Aortic sclerosis (8%), Valvular heart disease (6%), Atrial septal defect (0.9%), atrial myxoma (0.9%). According to the above findings, hypertensive heart disease (left ventricular hypertrophy (LVH) + diastolic dysfunction) was the main echocardiographic finding among our patients. This observation is consistent with other studies: LVH and abnormal LV geometry are independently associated with increased stroke risk [65] . In hypertensive patients, concentric and eccentric hypertrophy was associated with an ≈2-fold increase in stroke incidence, whereas concentric remodeling did not carry increased risk [66] [67] .

Aortic sclerosis: The early build-up of calcium deposits that causes the valve to be thicker and more rigid than normal. Aortic sclerosis is diagnosed on echocardiography as focal areas of increased echogenicity on the valve leaflets with normal valve motion and a normal, or only mildly increased, antegrade velocity across the valve [68] - [70] . In our study (8%) of the cases were they have this finding on echocardiography.

Atrial septal defect: The association of ASD with cerebral embolic events has been less well studied. In one series of 103 patients (mean age 52 years) with a presumed paradoxical embolism and an atrial septal abnormality undergoing percutaneous closure, a PFO alone was present in 81, an ASD alone in 12, and both a PFO and ASD in 10 [71] [72] . In our study only one case (0.9%), was had this finding (Atrial septal defect).

Atrialmyxoma: The most common benign cardiac tumour, is found more commonly in young adults with stroke or transient ischemic attack (1 in 250) than in older patients with these problems (1 in 750). Strokes are often recurrent, and may be embolic or hemorrhagic, the presentation ranging from progressive multi-infarct dementia, to massive embolic stroke causing death. Because tumour fragments or adherent thrombus may embolize [73] [74] . In our study only one case (0.9%) was detected by transthoracic echocardiography.

5. Conclusions

・ Hypertension is the leading risk factor of stroke. It is therefore essential to detect and treat hypertension at its outset.

・ Stroke incidence increases with age and it is more common in male gender.

・ Echocardiography is a useful test as it is cheap, non-invasive and available, to find risk factors for stroke or a complication of these risk factors on the heart.

・ Normal total serum cholesterol (TSC) does not exclude the absence of dyslipidemia, as most of our patients have low serum HDL, and or high LDL.

・ High TSC and low serum HDL are mostly associated with ischemic stroke.

6. Recommendations

1) Hypertension is the main risk factor for stroke, so early diagnosis and prompt management of it is the main stay in preventing stroke.

2) Inpatient stroke unit operational under the direction of stroke director.

3) Stroke clinic to provide outpatient consultations for stroke care.

4) Ongoing program for primary and secondary stroke prevention.

5) Stroke nurse-coordinator.

Cite this paper

Mohamed, A.S. and Alshekhani, M.A.M. (2016) Risk Factors for Stroke in Sulaimaniyah Iraqi Kurdistan Region-Iraq. International Journal of Clinical Medicine, 7, 639-651.


  1. 1. Australian Institute of Health and Welfare (AIHW) (2005) Australian Hospital Statistics 2003-04. AIHW Cat. No. HSE 37. AIHW, Canberra.

  2. 2. Hankey, G.J. (2000) Transient Ischaemic Attacks and Stroke. Medical Journal of Australia, 172, 394-400.

  3. 3. National Stroke Foundation (2003) National Clinical Guidelines for Acute Stroke Management Melbourne: National Stroke Foundation.

  4. 4. Modan, B. and Wagener, D.K. (1992) Some Epidemiological Aspects of Stroke: Mortality/ Morbidity Trend, Age, Sex, Race, Socioeconomic Status. Stroke, 23, 1230-1236.

  5. 5. AD - Department of Neurology, New England Medical Center, Boston, MA 02111, PMID-2671793.

  6. 6. Hart, C., Davey Smith, G. and Hole, D. (1999) Risk Factors and 20 Year Stroke Mortality in Men and Women in the Renfrew/Paisley Study in Scotland. Stroke, 30, 1999-2007.

  7. 7. Sacco, R., Benjamin, E., Broderick, J., Dyken, M., Easton, J., Feinburg, W., Goldstein, L., Gorelick, P., Howard, G., Kittner, S., Manolio, T., Whisnant, J. and Wolf, P. (1997) American Heart Association Conference IV: Prevention and Rehabilitation of Stroke: Risk Factors. Stroke, 28, 1507-1517.

  8. 8. (1993) Heart and Stroke Facts. American Heart Association, Dallas.

  9. 9. Wolf, P.A. (1998) Prevention of Stroke. Lancet, 352, 15-18.

  10. 10. Park, J.E. and Park, K. (1995) Stroke: Textbook of Preventive and Social Medicine. 15th Edition, M/S Banarsidas Bhanot Publisher, Jabalpur, 245-246.

  11. 11. Ali, L., Jamil, H. and Shah, M.A. (1997) Risk Factors and Stroke. J CollPhysSurg Pak, 7, 7-10.

  12. 12. Stroke Unit Trialists’ Collaboration (2003) Organised Inpatient (Stroke Unit) Care for Stroke (Cochrane Review). The Cochrane Database of Systematic Reviews, Article ID: CD000197.

  13. 13. Malmgren, R., Warlow, C., Bamford, J. and Sandercock, P. (1990) Geographical and Secular Trends in Stroke Incidence. Lancet, 2, 1196-1200.

  14. 14. Sarkarati, D. and Reisdorff, E.J. (2002) Emergent CT Evaluation of Stroke. Emergency Medicine Clinics of North America, 20, 553-581.

  15. 15. El-Koussy, M., Guzman, R., Bassetti, C., et al. (2000) CT and MRI in Acute Hemorrhagic Stroke. Cerebrovascular Diseases, 10, 480-482.

  16. 16. Woisetschlager, C., Kittler, H., Oschatz, E., et al. (2000) Out-of-Hospital Diagnosis of Cerebral Infarction versus Intracranial Hemorrhage. Intensive Care Medicine, 26, 1561-1565.

  17. 17. Phillips, S.J. and Whisnant, J.P. (1992) Hypertension and the Brain: The National High Blood Pressure Education Program. Archives of Internal Medicine, 152, 938-945.

  18. 18. The Expert Panel (1988) Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Archives of Internal Medicine, 148, 36-69.

  19. 19. National Stroke Association (1994) Cost of Stroke. Stroke Clinical Updates, 5, 9-12.

  20. 20. Wolf, P.A., D’Agostino, R.B., Kannel, W.B., Bonita, R. and Belanger, A.J. (1991) Age as a Risk Factor for Stroke: The Framingham Study. JAMA, 259, 1026-1029.

  21. 21. Ferris, A., Robertson, R.M., Fabunmi, R. and Mosca, L. (2005) American Heart Association and American Stroke Association National Survey of Stroke Risk Awareness among Women. Circulation, 111, 1321-1326.

  22. 22. Al-Rajeh, S., Awada, A., Niazi, G. and Larbi, E. (1993) Stroke in a Saudi Arabian National Guard Community. Analysis of 500 Consecutive Cases from a Population-Based Hospital. Stroke, 24, 1635-1639.

  23. 23. Rodgers, A., MacMahon, S., Yee, T., Clark, T., Keung, C., Chen, Z., Bos, K. and Zhang, X. (1998) Blood Pressure, Cholesterol, and Stroke in Eastern Asia. The Lancet, 352, 1801-1807.

  24. 24. Park, J.K., Kim, H.J., Koh, S.B. and Koh, S.Y. (1998) Risk Factors for Hemorrhagic Stroke in Wonju, Korea. Yonsei Medical Journal, 39, 229-235.

  25. 25. MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A. and Stamler, J. (1990) Blood Pressure, Stroke, and Coronary Heart Disease, Part 1: Prolonged Differences in Blood Pressure: Prospective Observational Studies Corrected for the Regression Diluted Bias. The Lancet, 335, 765-774.

  26. 26. Kannel, W.B. (1996) Blood Pressure as a Cardiovascular Risk. JAMA, 275, 1571-1576.

  27. 27. Bronner, L.L., Kanter, D.S. and Manson, J.E. (1995) Primary Prevention of Stroke. The New England Journal of Medicine, 333, 1392-1400.

  28. 28. Fukiyama, K., Takishita, S., Muratani, H. and Kimura, Y. (1994) Trends in the Incidence of Cardiovascular Disease and the Treatment of Hypertension in Japan. Hypertension Research, 17, 215-219.

  29. 29. MRC Working Party (1992) Medical Research Council Trial of Treatment of Hypertension in Older Adults: Principal Results. BMJ, 304, 405-412.

  30. 30. Dunbabin, D.W. and Sandercock, P.A.G. (1990) Preventing Stroke by the Modification of Risk Factors. Stroke, 21, IV-36-39.

  31. 31. SHEP Cooperative Research Group (1992) Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons with Isolated Systolic Hypertension: Final Results of Systolic Hypertension in the Elderly Program (SHEP). JAMA, 265, 3255-3264.

  32. 32. Insua, J.T., Sacks, H.S., Lau, T., Lau, J., Reitman, D., Pagano, D. and Chalmers, T.C. (1994) Drug Treatment of Hypertension in the Elderly: A Meta-Analysis. Annals of Internal Medicine, 121, 355-362.

  33. 33. Staessen, J.A., Fagard, R., Thijs, L., Celis, H., Arabidze, G.G., Birkenh&aumlger, W.H., Bulpitt, C.J., de Leeuw, P.W., Dollery, C.T., Fletcher, A.E., Forette, F., Leonetti, G., Nachev, C., O’Brien, E.T., Rosenfeld, J., Rodicio, J.L., Tuomilehto, J. and Zanchetti, A. (1997) Randomised Double-Blind Comparison of Placebo and Active Treatment for Older Patients with Isolated Systolic Hypertension. The Lancet, 350, 757-764.

  34. 34. Amery, A., Birkenhager, W., Bulpitt, C., et al. (1991) Syst-Eur. A Multicentre Trial on the Treatment of Isolated Systolic Hypertension in the Elderly: Objectives, Protocol and Organization. Aging Clinical and Experimental Research, 3, 287-302.

  35. 35. Department of Health and Human Services (1990) The Health Benefits of Smoking Cessation: A Report of the Surgeon General. DHHS Publication No. (CDC) 90-8416, Government Printing Office, Washington DC.

  36. 36. Kawachi, I., Colditz, G.A., Stampfer, M.J., et al. (1993) Smoking Cessation and Decreased Risk of Stroke in Women. JAMA, 269, 232-236.

  37. 37. Shinton, R. and Beevers, G. (1989) Meta-Analysis of Relation between Cigarette Smoking and Stroke. BMJ, 298, 789-794.

  38. 38. Kubota, K., Yamaguchi, T., Abe, Y., Fugiwara, T., Hutazawa, J. and Matsuzawa, T. (1990) Effects of Smoking on Regional Cerebral Blood Flow in Neurologically Normal Subjects. Stroke, 14, 720-724.

  39. 39. Ruderman, N.B. and Haudenschild, C. (1984) Diabetes as an Atherogenic Factor. Progress in Cardiovascular Diseases, 26, 373-412.

  40. 40. Tanaka, H., Ueda, Y., Hayashi, M., et al. (1982) Risk Factors for Cerebral Hemorrhage and Cerebral Infarction in a Japanese Rural Community. Stroke, 13, 62-73.

  41. 41. Benfante, R., Yano, K., Hwang, L.J., Curb, J.D., Kagan, A. and Ross, W. (1994) Elevated Serum Cholesterol Is a Risk Factor for Both Coronary Heart Disease and Thromboembolic Stroke in Hawaiian Japanese Men. Implications of Shared risk. Stroke, 25, 814-820.

  42. 42. Atkins, D., Psaty, B.M., Koepsell, T.D., Longstreth Jr., W.T. and Larson, E.B. (1993) Cholesterol Reduction and the Risk for Stroke in Men: A Meta-Analysis of Randomized, Controlled Trials. Annals of Internal Medicine, 119, 136-145.

  43. 43. Jacobs, D., Blackburn, H., Higgins, M., et al. (1992) Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation, 86, 1046-1060.

  44. 44. Tell, G.S., Crouse, J.R. and Furberg, C.D. (1988) Relation between Blood Lipids, Lipoproteins, and Cerebrovascular Atherosclerosis. A Review. Stroke, 19, 423-430.

  45. 45. Kiechl, S., Willeit, J., Rungger, G., Egger, G., Oberhollenzer, F. and Bonora, E., for the Bruneck Study Group (1998) Alcohol Consumption and Atherosclerosis: What Is the Relation? Prospective Results from the Bruneck Study. Stroke, 29, 900-907.

  46. 46. Hillbom, M., Juvela, S. and Numminen, H. (1999) Alcohol Intake and the Risk of Stroke. European Journal of Preventive Cardiology, 6, 223-228.

  47. 47. Hannaford, P.C., Croft, P.R. and Kay, C.R. (1994) Oral Contraception and Stroke: Evidence from the Royal College of General Practitioners’ Oral Contraception Study. Stroke, 25, 935-942.

  48. 48. Thorogood, M., Mann, J., Murphy, M. and Vessey, M. (1992) Fatal Stroke and Use of Oral Contraceptives: Findings from a Case-Control Study. American Journal of Epidemiology, 136, 35-45.

  49. 49. Stampfer, M.J., Willett, W.C., Colditz, G.A., Speizer, F.E. and Hennekens, C.H. (1988) A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases. The New England Journal of Medicine, 319, 1313-1317.

  50. 50. Katerndahl, D.A., Realini, J.P. and Cohen, P.A. (1992) Oral Contraceptive Use and Cardiovascular Disease: Is the Relationship Real or Due to Study Bias? The Journal of Family Practice, 35, 147-157.

  51. 51. Sandercock, P., Bamford, J., Dennis, M., et al. (1992) Atrial Fibrillation and Stroke: Prevalence in Different Types of Stroke and Influence on Early and Long Term Prognosis (Oxfordshire Community Stroke Project). BMJ, 305, 1460-1465.

  52. 52. (1994) Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation: Analysis of Pooled Data from Five Randomized Controlled Trials. Archives of Internal Medicine, 154, 1449-1457.

  53. 53. Miller, V.T., Pearce, L.A., Feinberg, W.M., Rothrock, J.F., Anderson, D.C. and Hart, R.G. (1996) Differential Effect of Aspirin Versus Warfarin on Clinical Stroke Types in Patients with Atrial Fibrillation. Neurology, 46, 238-240.

  54. 54. Wannamethee, G., Shaper, A., Whincup, P. and Walker, M. (1998) Adult Height, Stroke and Coronary Heart Disease. American Journal of Epidemiology, 148, 1069-1076.

  55. 55. Longstreth Jr., W.T., Bernick, C., Fitzpatrick, A., et al. (2001) Frequency and Predictors of Stroke Death in 5,888 Participants in the Cardiovascular Health Study. Neurology, 56, 368-375.

  56. 56. Tefferi, A., Solberg, L.A. and Silverstein, M.N. (2000) A Clinical Update in Polycythemia Vera and Essential Thrombocythemia. The American Journal of Medicine, 109, 141-149.

  57. 57. Wannamethee, G., Perry, I.J. and Shaper, A.G. (1994) Haematocrit, Hypertension and Risk of Stroke. Journal of Internal Medicine, 235, 163-168.

  58. 58. Kannel, W.B., Gordon, T., Wolf, P.A. and McNamara, P. (1972) Hemoglobin and the Risk of Cerebral Infarction: The Framingham Study. Stroke, 3, 409-420.

  59. 59. Pearson, T.C. (1987) 2 Rheology of the Ab-solute Polycythaemias. Baillière’s Clinical Haematology, 1, 637-664.

  60. 60. Perloff, J.K., Marelli, A.J. and Miner, P.D. (1993) Risk of Stroke in Adults with Cyanotic Congenital Heart Disease. Circulation, 87, 1954-1959.

  61. 61. Jha, S.K., Anand, A.C., Sharma, V., Kumar, N. and Adya, C.M. (2004) Stroke at High Altitude: Indian Experience. High Altitude Medicine & Biology, 3, 21-27.

  62. 62. Pearson, T.C., Humphrey, P.R.D., Thomas, D.J. and Wetherley-Mein, G. (1999) Hematocrit, Blood Viscosity, Cerebral Blood Flow, and Vascular Occlusion. In: Lowe, G.D., Barbenel, J.C. and Forbes, C.D., Eds., Clinical Aspects of Blood Viscosity and Cell Deformability, Springer-Verlag, Berlin, 97-107.

  63. 63. Merino, A., Hauptma, P., Badimon, L., et al. (1992) Echocardiographic “Smoke” Is Produced by an Interaction of Erythrocytes and Plasma Proteins Modulated by Shear Forces. Journal of the American College of Cardiology, 20, 1661-1668.

  64. 64. Black, I.W., Hopkins, A.P., Lee, L.C.L. and Walsh, W.F. (1991) Left Atrial Spontaneous Echo Contrast: A Clinical and Echocardiographic Analysis. Journal of the American College of Cardiology, 18, 398-404.

  65. 65. Krumholz, H.M., Larson, M. and Levy, D. (1995) Prognosis of Left Ventricular Geometric Patterns in the Framingham Heart Study. Journal of the American College of Cardiology, 25, 879-884.

  66. 66. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B. and Castelli, W.P. (1990) Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study. The New England Journal of Medicine, 322, 1561-1566.

  67. 67. Schillaci, G., Verdecchia, P., Porcellati, G., Cuccurullo, O., Cosco, C. and Perticone, F. (2000) Continuous Relation between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension. Hypertension, 35, 580-586.

  68. 68. Boon, A., Lodder, J., Cheriex, E. and Kessels, F. (1996) Risk of Stroke in a Cohort of 815 Patients with Calcification of the Aortic Valve with or without Stenosis. Stroke, 27, 847-851.

  69. 69. Galante, A., Pietroiusti, A., Vellini, M., Piccolo, P., Possati, G., Bonis, M.D., Grillo, R.L., Fontana, C. and Favalli, C. (2001) C-Reactive Protein Is Increased in Patients with Degenerative Aortic Valvular Stenosis. Journal of the American College of Cardiology, 38, 1078-1082.

  70. 70. Gardin, J.M., McClelland, R., Kitzman, D., Lima, J.A.C., Bommer, W., Klopfenstein, H.S., Wong, N.D., Smith, V.E. and Gottdiener, J. (2001) M-Mode Echocardiographic Predictors of Six- to Seven-Year Incidence of Coronary Heart Disease, Stroke, Congestive Heart Failure, and Mortality in an Elderly Cohort (The Cardiovascular Health Study). The American Journal of Cardiology, 87, 1051-1057.

  71. 71. Meijboom, F., Hess, J., Szatmari, A., et al. (1993) Long Term Follow-Up (9 - 20 Years) after Surgical Closure of Atrial Septal Defect at Young Age. The American Journal of Cardiology, 72, 1431-1433.

  72. 72. Shah, D., Azhar, M., Oakley, C.M., Cleland, J.G.F. and Nihoyannopoulos, P. (1994) Natural History of Secundum Atrial Septal Defect in Adults after Medical or Surgical Treatment: A Historical Prospective Study. British Heart Journal, 71, 224-228.

  73. 73. Knepper, L.E., Biller, J., Adams Jr., H.P. and Bruno, A. (1988) Neurologic Manifestations of Atrial Myxoma. A 12-Year Experience and Review. Stroke, 19, 1435-1440.

  74. 74. Kessab, R., Wehbe, L., Badaoui, G., el Asmar, B., Jebara, V. and Ashoush, R. (1999) Recurrent Cerebrovascular Accident: Unusual and Isolated Manifestation of Myxoma of the Left Atrium. Le Journal Médical Libanais, 47, 246-250.